In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin (Q35270488)
scientific article
Language:
(P31) (Q13442814)
(P304) 1605-1608
(P407) (Q1860)
(P433) 8
(P478) 34
(P577) Wednesday, August 1, 1990
(P921) (Q421713)
(Q380136)
(P1433) (Q578004)
(P1476) "In vitro activities of fleroxacin, cefetamet, ciprofloxacin, ceftriaxone, trimethoprim-sulfamethoxazole, and amoxicillin-clavulanic acid against rare members of the family Enterobacteriaceae primarily of human (clinical) origin" (language: en)
(P2093) Hohl P
Lüthy-Hottenstein J
Zollinger-Iten J
Altwegg M
(P2860) (Q40216810)
(Q37265412)
(Q24644730)
(Q40811311)
(Q24658469)
(Q24644781)
(Q40208633)
(Q40207971)
(Q24653687)
(Q40209879)
(Q40194591)
(Q44226325)
(Q40194068)
(Q43548509)
(Q54353071)
(Q45197167)
(Q71771010)
(Q71118566)
(Q70646829)
(Q70413060)
other details
description scientific article

External Links